Skip to main content

Table 2 Results of inflammatory markers according to insulin resistance status

From: Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

 

All patients (N = 55)

Insulin resistance

Yes (n = 30)

No (n = 25)

p

White blood cell (ц/L) (min-max)

6700 (3100–11100)

7550 (4100–11100)

6100 (3100–8900)

0.004

Neutrophile (ц/L) (min-max)

4330 (1581–8991)

4805 (1827–8991)

3538 (1581–6597)

0.005

Lymphoctye (ц/L) (min-max)

1155 (585–2115)

1188 (640–1905)

1103 (585–2115)

0.4

Platelet (ц/L) (min-max)

282000 (172000–418000)

28200 (172000–41800)

262000 (174000–361000)

0.1

Neutrophil-lymphoctye ratio (NLR) (median) (min-max)

3.3 (min 1.9–max 7.6)

3.6 (min 2.2–7.6)

3.03 (min 1.9–max 5.2)

0.02

Platelet-lymphoctye ratio (PLR) (median) (min-max)

225.3 (min 101.6–max 418.8)

230.8 (min 126.8–max 390.2)

223.1 (min101.6–max 418.8)

0.8

Systemic inflammation index (SII) (median) (min-max)

963 (min 440–max 2458)

999 (min 511–max 2458)

884 (min 440–max 1438)

0.01

CRP (mg/L) (median) (min-max)

3.4 (1.59–43)

4.3 (2–43)

3.3 (1.5–12.5)

0.01